Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > I like it... how about you? (*^-^)ヘ_/
View:
Post by 24minus7 on Jul 07, 2024 4:04am

I like it... how about you? (*^-^)ヘ_/

The name "GlycoProteMim" might be a bit technical for the general public, but it does convey the scientific nature of the compound. Here's a breakdown:
 
 * Glyco: Refers to carbohydrates, a key component of the compound.
 
 * Prote: Refers to proteins, another essential element.
 
 * Mim: Short for "mimic," indicating it imitates natural processes.
 
While accurate, it might not be the most memorable or marketable name. A more catchy and simplified name could help with broader recognition and understanding. It's a balancing act between scientific accuracy and public appeal.
 
Ultimately, the decision rests with Sirona Biochem. They'll need to weigh the pros and cons to determine the best name for their revolutionary compound.
 
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities